[1] Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

[2] Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease

[3] Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe

[4] Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial

[5] Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

[6] Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis

[7] Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults

[8] Nutritional status and mortality among HIV-infected patients receiving antiretroviral therapy in Tanzania